Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donggun Kim

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Kidney International|November 4, 2023
Chromatin accessibility analysis and architectural profiling of human kidneys reveal key cell types and a regulator of diabetic kidney diseaseMinho Eun, Donggun Kim, So-I Shin, et al.
Journal of the American Society of Nephrology : JASN|October 1, 2024
METTL3-Mediated N 6 -Methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney FibrosisYu-Cheng Tsai, Tsung-Han Hsieh, Yuan-Ru Liao, et al.
Pharmaceutics|October 29, 2025
Design, Synthesis and Biological Evaluation of Pyrazolopyrimidine Derivatives as Aryl Hydrocarbon Receptor Antagonists for Colorectal Cancer ImmunotherapyByeong Wook Choi, Jae-Eon Lee, Da Bin Jeon, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Kidney International|November 4, 2023
Chromatin accessibility analysis and architectural profiling of human kidneys reveal key cell types and a regulator of diabetic kidney diseaseMinho Eun, Donggun Kim, So-I Shin, et al.
Journal of the American Society of Nephrology : JASN|October 1, 2024
METTL3-Mediated N 6 -Methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney FibrosisYu-Cheng Tsai, Tsung-Han Hsieh, Yuan-Ru Liao, et al.
Pharmaceutics|October 29, 2025
Design, Synthesis and Biological Evaluation of Pyrazolopyrimidine Derivatives as Aryl Hydrocarbon Receptor Antagonists for Colorectal Cancer ImmunotherapyByeong Wook Choi, Jae-Eon Lee, Da Bin Jeon, et al.
Pageof 2